ATE312823T1 - Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen - Google Patents
Verfahren zur herstellung heteroarylsubstituierter ureaverbindungenInfo
- Publication number
- ATE312823T1 ATE312823T1 AT00941745T AT00941745T ATE312823T1 AT E312823 T1 ATE312823 T1 AT E312823T1 AT 00941745 T AT00941745 T AT 00941745T AT 00941745 T AT00941745 T AT 00941745T AT E312823 T1 ATE312823 T1 AT E312823T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- substituted urea
- urea compounds
- heteroaryl
- compounds
- Prior art date
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000037976 chronic inflammation Diseases 0.000 abstract 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 150000003672 ureas Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14309499P | 1999-07-09 | 1999-07-09 | |
| PCT/US2000/017655 WO2001004115A2 (en) | 1999-07-09 | 2000-06-27 | Novel process for synthesis of heteroaryl-substituted urea compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE312823T1 true ATE312823T1 (de) | 2005-12-15 |
Family
ID=22502581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00941745T ATE312823T1 (de) | 1999-07-09 | 2000-06-27 | Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US6583282B1 (de) |
| EP (1) | EP1200411B1 (de) |
| JP (1) | JP4162406B2 (de) |
| AT (1) | ATE312823T1 (de) |
| CA (1) | CA2374737C (de) |
| DE (1) | DE60024830T2 (de) |
| ES (1) | ES2253233T3 (de) |
| MX (1) | MXPA02000314A (de) |
| WO (1) | WO2001004115A2 (de) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7517880B2 (en) * | 1997-12-22 | 2009-04-14 | Bayer Pharmaceuticals Corporation | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| EP1140840B1 (de) * | 1999-01-13 | 2006-03-22 | Bayer Pharmaceuticals Corp. | -g(v)-carboxyaryl substituierte diphenyl harnstoffe als raf kinase inhibitoren |
| US7351834B1 (en) | 1999-01-13 | 2008-04-01 | Bayer Pharmaceuticals Corporation | ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| EP2298311B1 (de) | 1999-01-13 | 2012-05-09 | Bayer HealthCare LLC | Omega-carboxyarylsubstituierte-Diphenyl-Harnstoffe als p38-Kinasehemmer |
| CA2374737C (en) * | 1999-07-09 | 2008-02-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Novel process for synthesis of heteroaryl-substituted urea compounds |
| ES2292488T3 (es) * | 1999-11-16 | 2008-03-16 | Boehringer Ingelheim Pharmaceuticals Inc. | Derivados de la urea, como agentes antiinflamatorios. |
| US6565880B2 (en) | 2000-07-24 | 2003-05-20 | Boehringer Ingelheim Pharmaceuticals, Inc. | Oral dosage formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea |
| MXPA03006749A (es) | 2001-02-15 | 2004-05-31 | Boehringer Ingelheim Pharma | Proceso para la sintesis de compuestos de urea sustituidos con heteroarilo, utiles como agentes antiinflamatorios. |
| JP2005504727A (ja) * | 2001-04-13 | 2005-02-17 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 抗炎症薬として有用なウレア化合物 |
| EP1709965A3 (de) | 2001-07-11 | 2006-12-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Methode zur Behandlung von zytokinvermittelten Erkrankungen |
| DK1478358T3 (da) | 2002-02-11 | 2013-10-07 | Bayer Healthcare Llc | Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese |
| WO2003068229A1 (en) | 2002-02-11 | 2003-08-21 | Bayer Pharmaceuticals Corporation | Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors |
| EP1480973B1 (de) * | 2002-02-25 | 2008-02-13 | Boehringer Ingelheim Pharmaceuticals Inc. | 1,4-disubstituierte benzokondensierte cycloalkyl-harnstoffverbindungen zur behandlung von zytokinvermittelten erkrankungen |
| US7056925B2 (en) | 2002-08-13 | 2006-06-06 | Abbott Laboratories | Urea kinase inhibitors |
| US20040138216A1 (en) * | 2002-12-23 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for the preparation of an essentially pure polymorph of an n-pyrazolyl-n'-naphthyl-urea |
| US7399866B2 (en) * | 2003-01-14 | 2008-07-15 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| UY28213A1 (es) | 2003-02-28 | 2004-09-30 | Bayer Pharmaceuticals Corp | Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos. |
| US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| US6887855B2 (en) | 2003-03-17 | 2005-05-03 | Pharmion Corporation | Forms of 5-azacytidine |
| US6943249B2 (en) * | 2003-03-17 | 2005-09-13 | Ash Stevens, Inc. | Methods for isolating crystalline Form I of 5-azacytidine |
| EP1636585B2 (de) | 2003-05-20 | 2012-06-13 | Bayer HealthCare LLC | Diaryl-harnstoffe mit kinasehemmender wirkung |
| WO2004113352A1 (en) * | 2003-06-19 | 2004-12-29 | Amedis Pharmaceuticals Ltd. | Silylated heterocyclylurea derivatives as cytokine-inhibitors |
| PL1663978T3 (pl) | 2003-07-23 | 2008-04-30 | Bayer Healthcare Llc | Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów |
| KR101024904B1 (ko) * | 2003-08-14 | 2011-03-31 | 엘지전자 주식회사 | 기록매체, 기록방법, 기록장치 및 기록재생시스템 |
| SG146624A1 (en) * | 2003-09-11 | 2008-10-30 | Kemia Inc | Cytokine inhibitors |
| CA2547837A1 (en) * | 2003-12-18 | 2005-07-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Polymorph of birb 796, a p38map kinase inhibitor |
| US7838524B2 (en) | 2004-04-30 | 2010-11-23 | Bayer Healthcare Llc | Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| US7507735B2 (en) | 2004-06-17 | 2009-03-24 | Cytokinetics, Inc. | Compounds, compositions and methods |
| DOP2006000051A (es) | 2005-02-24 | 2006-08-31 | Lilly Co Eli | Inhibidores de vegf-r2 y métodos |
| DE102005048390A1 (de) * | 2005-10-10 | 2007-04-19 | Siemens Ag | Verfahren und Einrichtung zur Bewegungsführung eines bewegbaren Maschinenelementes einer Maschine |
| WO2007043414A1 (ja) | 2005-10-11 | 2007-04-19 | Nikon Corporation | 多層膜反射鏡、多層膜反射鏡の製造方法、光学系、露光装置及びデバイスの製造方法 |
| TW200808321A (en) | 2005-12-15 | 2008-02-16 | Cytokinetics Inc | Certain chemical entities, compositions and methods |
| WO2007075377A2 (en) * | 2005-12-15 | 2007-07-05 | Cytokinetics, Inc. | Certain chemical entities, compositions and methods |
| US7825120B2 (en) * | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
| US20070208000A1 (en) * | 2005-12-15 | 2007-09-06 | Morgan Bradley P | Certain chemical entities, compositions and methods |
| WO2007078815A2 (en) * | 2005-12-16 | 2007-07-12 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| WO2007078839A2 (en) * | 2005-12-19 | 2007-07-12 | Cytokinetics, Inc. | Compounds, compositions and methods |
| WO2007089646A1 (en) * | 2006-01-31 | 2007-08-09 | Array Biopharma Inc. | Kinase inhibitors and methods of use thereof |
| US8604031B2 (en) | 2006-05-18 | 2013-12-10 | Mannkind Corporation | Intracellular kinase inhibitors |
| BRPI0920707A2 (pt) | 2008-10-02 | 2015-12-29 | Respivert Ltd | compostos |
| GB0818033D0 (en) | 2008-10-02 | 2008-11-05 | Respivert Ltd | Novel compound |
| MX2011006219A (es) | 2008-12-11 | 2011-06-28 | Respivert Ltd | Inhibidores de la proteina cinasa activada por el mitogeno p38. |
| GB0905955D0 (en) | 2009-04-06 | 2009-05-20 | Respivert Ltd | Novel compounds |
| BRPI1004176A2 (pt) * | 2010-10-25 | 2015-08-11 | Univ Rio De Janeiro | Compostos aril e/ou hetero aril uréias funcionalizados; processo de síntese desses composto; composição farmacêutica contendo tais compostos e usos |
| EP2578582A1 (de) | 2011-10-03 | 2013-04-10 | Respivert Limited | 1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) Harnstoffe als p38 MAP Kinasehemmer |
| PL2763984T3 (pl) | 2011-10-03 | 2016-10-31 | 1-pirazolilo-3-(4-((2-anilinopirymidyno-4-ilo)oksy)naftaleno-1-ilo)moczniki jako inhibitory kinazy p38 MAP | |
| MY167216A (en) | 2011-12-09 | 2018-08-14 | Chiesi Farm Spa | Kinase inhibitors |
| GB201214750D0 (en) | 2012-08-17 | 2012-10-03 | Respivert Ltd | Compounds |
| WO2014033447A2 (en) | 2012-08-29 | 2014-03-06 | Respivert Limited | Kinase inhibitors |
| US9783556B2 (en) | 2012-08-29 | 2017-10-10 | Respivert Limited | Kinase inhibitors |
| EP2890460B1 (de) | 2012-08-29 | 2017-02-22 | Respivert Limited | Kinaseinhibitoren |
| GB201215357D0 (en) | 2012-08-29 | 2012-10-10 | Respivert Ltd | Compounds |
| EP2925742B1 (de) | 2012-11-16 | 2016-10-26 | Respivert Limited | Kinaseinhibitoren |
| EP2970190A1 (de) | 2013-03-14 | 2016-01-20 | Respivert Limited | Kinaseinhibitoren |
| EP2981534B1 (de) | 2013-04-02 | 2017-07-19 | Topivert Pharma Limited | Kinasehemmer auf der basis von n-alkyl-pyrazolen |
| EP2981535B8 (de) | 2013-04-02 | 2021-03-10 | Oxular Acquisitions Limited | Als kinaseinhibitoren nützliche harnstoffderivate |
| JP6514703B2 (ja) | 2013-12-20 | 2019-05-15 | トピバート ファーマ リミテッド | キナーゼインヒビターとして有用な尿素誘導体 |
| ES2774249T3 (es) | 2014-02-14 | 2020-07-20 | Respivert Ltd | Compuestos heterocíclicos aromáticos como compuestos antiinflamatorios |
| MA40775A (fr) | 2014-10-01 | 2017-08-08 | Respivert Ltd | Dérivé d'acide 4-(4-(4-phényluréido-naphtalén -1-yl) oxy-pyridin-2-yl) amino-benzoïque utilisé en tant qu'inhibiteur de la kinase p38 |
| AU2017245888B2 (en) | 2016-04-06 | 2021-05-13 | Oxular Acquisitions Limited | Kinase inhibitors |
| ES2927715T3 (es) | 2017-10-05 | 2022-11-10 | Fulcrum Therapeutics Inc | Inhibidores de la quinasa p38 reducen la expresión de dux4 y de los genes que le siguen para el tratamiento de la FSHD |
| CN109053623B (zh) * | 2018-08-27 | 2020-08-04 | 济南悟通生物科技有限公司 | 一种4-甲基-5-噻唑甲醛的制备方法 |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US447624A (en) * | 1891-03-03 | Corn-harvester | ||
| US3291808A (en) * | 1961-08-14 | 1966-12-13 | Parke Davis & Co | Naphthalene diamine compounds and methods for their production |
| US4105766A (en) * | 1977-08-19 | 1978-08-08 | Sterling Drug Inc. | 4,5-Dihydro-5-oxopyrazolo[1,5-a]quinazoline-3-carboxylic acid derivatives |
| US4447624A (en) * | 1980-08-27 | 1984-05-08 | Eastman Kodak Company | Preparation of thiophenes |
| HU185294B (en) | 1980-12-29 | 1984-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing substituted urea derivatives |
| US4436567A (en) * | 1982-03-22 | 1984-03-13 | Weikert Roy J | Method for joining webs of aseptic pouches |
| JPS61228444A (ja) | 1985-04-02 | 1986-10-11 | Fuji Photo Film Co Ltd | ハロゲン化銀カラ−写真感光材料 |
| EP0272866A1 (de) | 1986-12-23 | 1988-06-29 | Merck & Co. Inc. | 1,4-Benzodiazepine mit 5-gliedrigen heterocyclischen Ringen |
| GB8908869D0 (en) | 1989-04-19 | 1989-06-07 | Shell Int Research | A process for the preparation of aromatic ureas |
| WO1991004027A1 (en) | 1989-09-15 | 1991-04-04 | Pfizer Inc. | New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| DD293352A5 (de) | 1990-04-06 | 1991-08-29 | Adw,Zi Fuer Organische Chemie,De | Verfahren zur herstellung von 2,2-disubstituierten 1-acyl- und/oder 9-acyl-2,3-dihydro-imidazo/1,2-a/benzimidazol-3-onen |
| US5162360A (en) * | 1991-06-24 | 1992-11-10 | Warner-Lambert Company | 2-heteroatom containing urea and thiourea ACAT inhibitors |
| IL104369A0 (en) * | 1992-01-13 | 1993-05-13 | Smithkline Beecham Corp | Novel compounds and compositions |
| RU94046149A (ru) | 1992-05-28 | 1996-11-27 | Пфайзер Инк. (US) | Новые n-арил и n-гетероарил производные мочевины как ингибиторы ацил кофермента а:холестерин ацил трансферазы (асат) фармацевтическая композиция, способ ингибирования (асат) |
| US5342942A (en) | 1992-06-09 | 1994-08-30 | Warner-Lambert Company | Pyrazoloquinazolone derivatives as neurotrophic agents |
| GB9302275D0 (en) | 1993-02-05 | 1993-03-24 | Smithkline Beecham Plc | Novel compounds |
| WO1994022872A1 (fr) | 1993-03-30 | 1994-10-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Inhibiteur d'adhesion cellulaire et compose a base de thienotriazolodiazepine |
| US5871934A (en) * | 1993-09-17 | 1999-02-16 | Smithkline Beecham Corporation | Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins |
| US5869043A (en) * | 1993-09-17 | 1999-02-09 | Smithkline Beecham Corporation | Drug binding protein |
| US5783664A (en) * | 1993-09-17 | 1998-07-21 | Smithkline Beecham Corporation | Cytokine suppressive anit-inflammatory drug binding proteins |
| JPH11503110A (ja) | 1995-02-17 | 1999-03-23 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ−８受容体拮抗剤 |
| IL118544A (en) | 1995-06-07 | 2001-08-08 | Smithkline Beecham Corp | History of imidazole, the process for their preparation and the pharmaceutical preparations containing them |
| US5739143A (en) * | 1995-06-07 | 1998-04-14 | Smithkline Beecham Corporation | Imidazole compounds and compositions |
| WO1997016442A1 (en) | 1995-10-31 | 1997-05-09 | Merck & Co., Inc. | Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| US6074862A (en) | 1995-12-20 | 2000-06-13 | Signal Pharmaceuticals Inc. | Mitogen-activated protein kinase kinase MEK6 and variants thereof |
| US6096748A (en) | 1996-03-13 | 2000-08-01 | Smithkline Beecham Corporation | Pyrimidine compounds useful in treating cytokine mediated diseases |
| WO1997035856A1 (en) | 1996-03-25 | 1997-10-02 | Smithkline Beecham Corporation | Novel treatment for cns injuries |
| WO1997035855A1 (en) | 1996-03-25 | 1997-10-02 | Smithkline Beecham Corporation | Novel treatment for cns injuries |
| EP0914450A1 (de) | 1996-05-20 | 1999-05-12 | Signal Pharmaceuticals, Inc. | Mitogenaktivierte proteinkinase p38-2 und methoden zu deren verwendung |
| US5948885A (en) * | 1996-05-20 | 1999-09-07 | Signal Pharmaceuticals, Inc. | Mitogen-activated protein kinase p38-2 and methods of use therefor |
| AU708883B2 (en) * | 1996-06-10 | 1999-08-12 | Merck & Co., Inc. | Substituted imidazoles having cytokine inhibitory activity |
| CA2258728C (en) | 1996-06-19 | 2011-09-27 | Rhone Poulenc Rorer Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| WO1998007425A1 (en) | 1996-08-21 | 1998-02-26 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
| EP0932666B1 (de) | 1996-10-09 | 2004-12-15 | Medical Research Council | Map-kinase: polypeptide, polynukleotide und ihre verwendung |
| US6043246A (en) | 1996-12-03 | 2000-03-28 | Banyu Pharmaceutical Co., Ltd. | Urea derivatives |
| US6147080A (en) | 1996-12-18 | 2000-11-14 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
| US6376214B1 (en) | 1997-02-18 | 2002-04-23 | Smithkline Beecham Corporation | DNA encoding a novel homolog of CSBP/p38 MAP kinase |
| AU7585598A (en) | 1997-05-23 | 1998-12-11 | Bayer Corporation | Raf kinase inhibitors |
| EP1019040B1 (de) | 1997-05-23 | 2004-09-29 | Bayer Corporation | Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen |
| US6093742A (en) | 1997-06-27 | 2000-07-25 | Vertex Pharmaceuticals, Inc. | Inhibitors of p38 |
| US5851812A (en) * | 1997-07-01 | 1998-12-22 | Tularik Inc. | IKK-β proteins, nucleic acids and methods |
| US5858041A (en) * | 1997-08-22 | 1999-01-12 | David Luetkemeyer | Clean air system |
| CA2223075A1 (en) | 1997-12-02 | 1999-06-02 | Smithkline Beecham Corporation | Drug binding protein |
| IL136768A0 (en) | 1997-12-22 | 2001-06-14 | Bayer Ag | INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS |
| CA2315720A1 (en) | 1997-12-22 | 1999-07-01 | Bayer Corporation | Inhibition of p38 kinase activity using substituted heterocyclic ureas |
| DE69830513T2 (de) | 1997-12-22 | 2006-03-16 | Bayer Pharmaceuticals Corp., West Haven | HEMMUNG DER p38 KINASE UNTER VERWENDUNG VON SYMMETRISCHEN UND ASYMMETRISCHEN DIPHENYLHARNSTOFFEN |
| JP4437270B2 (ja) | 1997-12-22 | 2010-03-24 | バイエル コーポレイション | 置換複素環式尿素を用いたｒａｆキナーゼの阻害 |
| NZ505845A (en) | 1997-12-22 | 2003-10-31 | Bayer Ag | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas |
| WO1999046244A1 (en) | 1998-03-12 | 1999-09-16 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
| UA73492C2 (en) * | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
| MXPA01008440A (es) * | 1999-02-22 | 2002-04-24 | Boehringer Ingelheim Pharma | Derivados heterociclicos policiclos como agentes anti-inflamatorios.. |
| TR200102817T2 (tr) * | 1999-03-12 | 2002-05-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Antiinflamatuar ajanlar olarak faydalı bileşikler |
| WO2000055152A1 (en) * | 1999-03-12 | 2000-09-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aromatic heterocyclic compounds as anti-inflammatory agents |
| CA2374737C (en) * | 1999-07-09 | 2008-02-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Novel process for synthesis of heteroaryl-substituted urea compounds |
-
2000
- 2000-06-27 CA CA002374737A patent/CA2374737C/en not_active Expired - Lifetime
- 2000-06-27 ES ES00941745T patent/ES2253233T3/es not_active Expired - Lifetime
- 2000-06-27 DE DE60024830T patent/DE60024830T2/de not_active Expired - Lifetime
- 2000-06-27 MX MXPA02000314A patent/MXPA02000314A/es active IP Right Grant
- 2000-06-27 AT AT00941745T patent/ATE312823T1/de active
- 2000-06-27 EP EP00941745A patent/EP1200411B1/de not_active Expired - Lifetime
- 2000-06-27 JP JP2001509725A patent/JP4162406B2/ja not_active Expired - Lifetime
- 2000-06-27 WO PCT/US2000/017655 patent/WO2001004115A2/en not_active Ceased
- 2000-07-06 US US09/611,109 patent/US6583282B1/en not_active Expired - Lifetime
-
2002
- 2002-11-20 US US10/300,448 patent/US6753426B2/en not_active Expired - Lifetime
-
2003
- 2003-02-10 US US10/361,731 patent/US6835832B2/en not_active Expired - Lifetime
- 2003-02-10 US US10/361,440 patent/US6894173B2/en not_active Expired - Lifetime
- 2003-02-10 US US10/361,719 patent/US6774233B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6774233B2 (en) | 2004-08-10 |
| US6583282B1 (en) | 2003-06-24 |
| JP2003504366A (ja) | 2003-02-04 |
| JP4162406B2 (ja) | 2008-10-08 |
| US6835832B2 (en) | 2004-12-28 |
| US20030166930A1 (en) | 2003-09-04 |
| US20030166931A1 (en) | 2003-09-04 |
| ES2253233T3 (es) | 2006-06-01 |
| US20030109703A1 (en) | 2003-06-12 |
| DE60024830T2 (de) | 2006-06-14 |
| CA2374737A1 (en) | 2001-01-18 |
| DE60024830D1 (de) | 2006-01-19 |
| US20030181718A1 (en) | 2003-09-25 |
| MXPA02000314A (es) | 2004-06-22 |
| WO2001004115A3 (en) | 2001-09-27 |
| EP1200411B1 (de) | 2005-12-14 |
| WO2001004115A2 (en) | 2001-01-18 |
| US6894173B2 (en) | 2005-05-17 |
| US6753426B2 (en) | 2004-06-22 |
| EP1200411A2 (de) | 2002-05-02 |
| CA2374737C (en) | 2008-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60024830D1 (de) | Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen | |
| AU1617901A (en) | Urea derivatives as anti-inflammatory agents | |
| YU39101A (sh) | Aromatična hetrerociklična jedinjenja kao antiinflamatorni agensi | |
| CA2361998A1 (en) | Aromatic heterocyclic compounds as anti-inflammatory agents | |
| DE60319066D1 (de) | 1,4-disubstituierte benzokondensierte cycloalkyl-harnstoffverbindungen zur behandlung von zytokinvermittelten erkrankungen | |
| BG105880A (en) | Compounds useful as anti-inflammatory agents | |
| BR0212345A (pt) | Composto, processo para preparar um composto, uso de um composto, método para produzir um efeito inibidor de ácido de bile ileal em um animal de sangue quente e composição farmacêutica | |
| WO2005016918A3 (en) | Heterocyclic n-aryl carboxamides as cytokine inhibitors | |
| ATE533765T1 (de) | Pyrroloä2,3-cüpyridinderivate und verfahren für deren herstellung | |
| YU94103A (sh) | Novi derivati sulfonske kiseline | |
| TR28332A (tr) | Arilasetik asit türevleri. | |
| MXPA04002282A (es) | Nuevos compuestos y preparaciones como inhibidores de la catepsina. | |
| ATE329909T1 (de) | 1,2,3-triazolamid-derivate als cytokininhibitoren | |
| EA200000204A1 (ru) | Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов | |
| WO2004033423A3 (en) | Anticancer compounds | |
| AU2003265924A1 (en) | Benzimidazolones and their use as cytokine inhibitors | |
| ATE299851T1 (de) | Verfahren zur herstellung von zwischenprodukten | |
| ATE248141T1 (de) | Verfahren zur herstellung von (r) und (s)- aminocarnitin und deren derivative aus d- und l- aspargin säure | |
| WO2003070696A3 (de) | Substituierte arylketone | |
| BR9910370A (pt) | Compostos de cefalosporina, processo para preparar compostos de cefalosporina, e, composições antimicrobianas | |
| WO2003029244A8 (en) | Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives | |
| WO1995019400A3 (de) | Additive, deren herstellung, diese enthaltende kathodisch abscheidbare elektrotauchlackbäder und deren verwendung | |
| BG106916A (bg) | Метод за получаване на естери на арил-иминометил-карбаминова киселина | |
| RU94015603A (ru) | Производные 3-гидроксиантраниловой кислоты, способ их получения, фармацевтическая композиция, способ лечения и промежуточные соединения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1200411 Country of ref document: EP |